Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2025-12-25 @ 1:40 PM
NCT ID:
NCT03279692
Group ID:
EG000
Title:
Pembrolizumab
Description:
* Pembrolizumab will be administered every 3 weeks
* Pembrolizumab will be administered through IV infusion
Pembrolizumab: pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells
Deaths Number Affected:
15
Deaths Number At Risk:
None
Serious Number Affected:
10
Serious Number At Risk:
25
Other Number Affected:
25
Other Number At Risk:
25
Study:
NCT03279692
Results Section:
NCT03279692
Adverse Events Module:
NCT03279692